Individuals enrolled in Apple Health (Medicaid), Public Employees Benefits Board, and School Employees Benefits Board coverage - and those accessing behavioral health services - will not experience a disruption in care due to the federal government shutdown. In addition, health care providers will continue to be paid for the services they provide. We will continue to monitor the situation closely and share updates if anything changes.
Cardiac magnetic resonance angiography (CMRA) is an imaging modality that provides a mechanism to assess cardiac or vascular anatomy, function, perfusion, and tissue characteristics in a highly reproducible manner, during a single examination. CMRA can also be used to determine coronary artery patency in adults with coronary artery disease (CAD), and as a diagnostic modality for patients with suspected anomalous coronary anatomy.
Status: Decision completed
There have been a number of CMRA technological advances in the past decade; however, its accuracy and clinical utility for diagnosis in routine clinical practice are unclear. This topic was selected because of medium-level concerns about the safety and efficacy of CMRA and high-level concern about costs. The objective of the health technology assessment (HTA) is to evaluate the diagnostic validity (i.e., accuracy), clinical utility (i.e., effectiveness), safety, and cost-effectiveness of CMRA in adults or children with known or suspected coronary vessel anomalies or congenital heart disease.
| Type | Materials |
|---|---|
| Assessment (2021) |
